The Triple IFA is an immunofluorescence assay (IFA) for the qualitative and semi-quantitative determination of IgG antibodies in human serum (ANA/AMA/ASMA/APCA) on tissue sections of rat liver, stomach and kidney. The Triple IFA is intended as an aid in the diagnosis of autoimmune diseases in conjunction with other clinical and laboratory findings. The immunoassay is designed for manual professional in vitro diagnostic use.
85048, 85096 – Triple IFA
Autoimmunity, Diagnostics, IFA
85048, 85096 – Triple IFA
Indirect immunofluorescence assay for the determination of IgG antibodies in human serum against smooth muscle
Available Downloads:
| Indication | Systemic autoimmune diseases |
|---|---|
| Format | Slides coated with cryostat tissue sections of rat liver, stomach and kidney |
| Total incubation time | 60 min |
| Sample volume | 10 µL serum |
| No. of determinations | 48 (12 x 4) or 96 (12 x 8) |
Related products
-
3850 – Anti-GP2 IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against glycoprotein 2 in human serum
-
3506 – Medizym® anti-IA2 M
Enzyme immunoassay for the quantitative determination of antibodies against Protein Tyrosine Phosphatase (IA2) in human serum
-
3810 – GliaDea IgG
Enzyme immunoassay for the quantitative determination of IgG antibodies against deamidated gliadin in human serum